Molecular Genetic Studies of Multiple Sclerosis in the Portuguese Population

Authors

  • Andreia Bettencourt UMIB - Instituto de Ciências Biomédicas Abel Salazar. Universidade do Porto. Porto. Portugal.
  • Ana Martins da Silva Serviço de Neurologia. Centro hospitalar do Porto - Hospital Geral de Santo António. UMIB - Instituto de Ciências Biomédicas Abel Salazar. Universidade do Porto. Porto. Portugal.
  • Paulo Pinho e Costa Instituto Nacional de Saúde Ricardo Jorge. Porto. Portugal.
  • Berta Martins Silva UMIB - Instituto de Ciências Biomédicas Abel Salazar. Universidade do Porto. Porto. Portugal.

DOI:

https://doi.org/10.20344/amp.66

Abstract

Multiple sclerosis (MS) is a chronic neuroinflammatory autoimmune disease believed to arise from complex interactions of both environmental and genetic factors. As in other complex diseases with autoimmune features, a genetic association with the human leukocyte antigen (HLA) complex is well documented. Association and genome-wide studies were performed in Portuguese patients with MS over several years. Genes such as HLA-DRB1, HLA-A, HFE, TNFA, CTLA-4, PTPN22 and ApoE were investigated. ApoE, PTPN22 1858T, CTLA-4 -318C, TNFA-308A, HFE C282Y and TLR9 T-1237C polymorphisms were not shown to be associated with the development of MS. The HLA-DRB1*15 allele was confirmed as the major genetic marker for susceptibility to MS. The presence of HLA–A*02 and TNFA -238A alleles decreased the risk of developing MS. Patients carrying the HFE C282Y variant seem to have a worse prognosis. The HLA-DRB1*15 and PTPN22 1858T variants were associated with a better outcome in this population.

Downloads

Download data is not yet available.

Downloads

Published

2012-08-30

How to Cite

1.
Bettencourt A, Martins da Silva A, Pinho e Costa P, Martins Silva B. Molecular Genetic Studies of Multiple Sclerosis in the Portuguese Population. Acta Med Port [Internet]. 2012 Aug. 30 [cited 2024 Apr. 19];25(4):224-30. Available from: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/66

Issue

Vol. 25 No. 4 (2012): July-August

Section

Review Articles

License

All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.

It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.

Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.

After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.

Crossref
Scopus
Google Scholar
Europe PMC